TLOG (TetraLogic Pharmaceuticals) Total Debt per Share: $1.24 (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Total Debt per Share?

TetraLogic Pharmaceuticals TLOG Total Debt per Share is $1.24 as of Sep. 2016.

$1.24 (As of Sep. 2016)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. TetraLogic Pharmaceuticals's Total Debt Per Share for the quarter that ended in Sep. 2016 was $1.24.

TetraLogic Pharmaceuticals Total Debt per Share Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Debt per Share Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Total Debt per Share
0.00 0.23 0.00 1.22 1.14

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.14 1.17 1.21 1.24

TetraLogic Pharmaceuticals Total Debt per Share Calculation

TetraLogic Pharmaceuticals's Total Debt Per Share for the fiscal year that ended in Dec. 2015 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(28.28+0.00)/24.77
=1.14

TetraLogic Pharmaceuticals's Total Debt Per Share for the quarter that ended in Sep. 2016 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(30.81+0.00)/24.77
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $1.24 mean?
TetraLogic Pharmaceuticals (TLOG) has a Total Debt per Share of $1.24 as of Sep. 2016. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Total Debt per Share too high?
TetraLogic Pharmaceuticals' current Total Debt per Share is $1.24.
How does TetraLogic Pharmaceuticals' Total Debt per Share compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Total Debt per Share of $1.24 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Total Debt per Share is $1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Total Debt per Share of $1.24. The current Total Debt per Share is $1.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Total Debt per Share is $1.24 as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.